Phase II Trial of Fludarabine Combined With Intravenous Treosulfan and Allogeneic Hematopoietic Stem-cell Transplantation in Patients With Lymphatic Malignancies.

Trial Profile

Phase II Trial of Fludarabine Combined With Intravenous Treosulfan and Allogeneic Hematopoietic Stem-cell Transplantation in Patients With Lymphatic Malignancies.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 23 Apr 2016

At a glance

  • Drugs Treosulfan (Primary) ; Fludarabine
  • Indications Follicular lymphoma; Graft-versus-host disease; Hodgkin's disease; Lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Apr 2016 Planned End Date changed from 1 Mar 2016 to 1 Apr 2018.
    • 19 Apr 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Apr 2018.
    • 02 Dec 2015 Planned End Date changed from 1 Mar 2014 to 1 Mar 2016, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top